Clinical Trial Update: Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chidamide in combination with venetoclax for retinoic acid- and arsenic-resistant acute promyelocytic leukemia; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Chidamide (chidamide)
• Venetoclax (venetoclax)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: APL | Phase 2 | Status: RECRUITING